MEK

MEK (Mitogen-activated protein kinase kinase, MAPKK) is a kinase enzyme which phosphorylates mitogen-activated protein kinases (MAPKs). The activated MAPK leads to the phosphorylation of downstream transcription factors that regulate various responses such as stress signaling, pathogen response, and hormone signaling.

In general, the MAPKKK phosphorylates a serine or threonine residue on a MAPKK, which sequentially activates a MAPK (ERK, p38 or JNK), the last protein in the cascade. Activation of the p38 MAPK occurs mainly through mitogen-activated protein kinase kinase 3 (MKK3) and MKK6 (sometimes MKK4). The JNK is regulated by two upstream MAP2Ks: MKK4 and MKK7. The highly homologous kinases, MEK1 and MEK2, act downstream of Ras and Raf to activate ERK mitogen-activated protein kinases.

共 3种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
MS432

MS432 是一种基于 PD0325901 和 von Hippel-Lindau 配体的创新型、高度选择性 MEK1 和 MEK2 PROTAC 降解剂,在小鼠体内显示出较高且长时间的血浆暴露量,对 HT29 细胞中 MEK1 和 MEK2 蛋白的 DC50 值分别为 31 nM 和 17 nM(粉色:MEK1 和 MEK2 靶蛋白配体;蓝色:VHL 配体 (MS-R95960);黑色:连接子 (MS-F00866))。

2672512-44-4
Degrader
99.72%
MS432
MS910

MS910 是一种高效选择性 MEK1/2 PROTAC 降解剂,在多种癌细胞中表现出有效的 MEK1/2 降解能力和抗增殖活性,如 HT-29(MEK1 DC50 = 118 nM,MEK2 DC50 = 55 nM)和 SK-MEL-28(MEK1 DC50 = 94 nM,MEK2 DC50 = 38 nM)细胞,常用于癌症研究(粉色:MEK1/2 配体 (MS-R85430);蓝色:CRBN 配体 (MS-H35153);黑色:连接子 (MS-T23521))。

2756323-28-9
Degrader
MS910
MS934

MS934 是一种新型改进的 VHL 招募 MEK1/2 PROTAC 降解剂,同时也降解 CRAF,可用于黑色素瘤、非小细胞肺癌 (NSCLC)、结直肠癌、原发性脑肿瘤和肝细胞癌等多种人类癌症的研究(粉色:MEK1 和 MEK2 配体 (MS-P92474);蓝色:VHL 配体 (MS-R95960);黑色:连接子 (MS-M90345))。

2756323-15-4
Degrader
98.48%
MS934

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础